WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2024)
Top pharmaceutical stocks in 2024 ranked by overall Zen Score. See the best pharmaceutical stocks to buy now, according to analyst forecasts for the drug manufacturers - specialty & generic industry.

Industry: Drug Manufacturers - Spec...
Ticker
Company
Performance Score
Market Cap
Revenue
EBITDA
Earnings
EPS
Revenue Growth Y/Y
Revenue Growth 5Y
Earnings Growth Y/Y
Earnings Growth 5Y
Earnings Date
KMDA
KAMADA LTD
$308.67M$149.55M$26.45M$12.46M$0.2513.33%3.85%N/A-17.14%
NBIX
NEUROCRINE BIOSCIENCES INC
$14.32B$1.98B$497.00M$369.70M$3.7723.99%30.76%462.69%N/A
PCRX
PACIRA BIOSCIENCES INC
$1.43B$681.75M$190.25M$70.47M$1.521.88%14.01%N/A54.98%
LNTH
LANTHEUS HOLDINGS INC
$5.52B$1.37B$674.08M$460.53M$6.7432.98%31.50%N/A43.70%
AMPH
AMPHASTAR PHARMACEUTICALS INC
$2.13B$676.21M$248.86M$154.69M$3.2030.38%16.43%67.54%129.74%2024-06-03
ANIP
ANI PHARMACEUTICALS INC
$1.29B$517.46M$128.31M$33.92M$1.6244.26%20.00%N/A6.72%
COLL
COLLEGIUM PHARMACEUTICAL INC
$1.06B$566.92M$358.62M$93.29M$2.818.00%14.25%N/AN/A
HCM
HUTCHMED (CHINA) LTD
$3.51B$838.00MN/A$100.78M$0.6096.52%31.38%N/AN/A
SIGA
SIGA TECHNOLOGIES INC
$541.24M$157.02M$102.76M$79.26M$1.1044.64%-20.22%144.44%-27.31%
SCYX
SCYNEXIS INC
$104.65M$140.39M$104.31M$101.33M$2.122,436.77%253.03%N/AN/A2024-06-19
ZTS
ZOETIS INC
$79.42B$8.73B$3.72B$2.39B$5.197.91%8.11%16.89%12.50%2024-05-22
CRON
CRONOS GROUP INC
$1.11B$93.03M-$106.26M-$57.04M-$0.1411.37%48.55%N/AN/A
ALKS
ALKERMES PLC
$4.09B$1.73B$438.76M$434.43M$2.6254.01%9.59%N/AN/A2024-05-31
ITCI
INTRA-CELLULAR THERAPIES INC
$6.86B$513.93M-$109.36M-$110.87M-$1.1665.45%N/AN/AN/A2024-06-14
RDY
DR REDDYS LABORATORIES LTD
$11.37B$2.99B$904.61M$547.73MN/A6.32%6.52%N/AN/A
TLRY
TILRAY BRANDS INC
$1.53B$743.25M-$186.62M-$351.95M-$0.4424.65%30.54%N/AN/A
PROC
PROCAPS GROUP SA
$300.11M$414.10M$75.58M$52.20M$0.52-4.80%N/A-13.33%N/A2024-06-28
DCPH
DECIPHERA PHARMACEUTICALS INC
$2.20B$174.91M-$183.52M-$190.42M-$2.2126.51%N/AN/AN/A2024-06-20
ZOM
ZOMEDICA CORP
$170.51M$25.97M-$37.34M-$36.77M-$0.0425.68%N/AN/AN/A
SBFM
SUNSHINE BIOPHARMA INC
$924.91k$24.09M-$3.82M-$4.51M-$19.00454.42%N/AN/AN/A
PAHC
PHIBRO ANIMAL HEALTH CORP
$745.27M$999.56M$79.80M$13.16M$0.332.19%3.64%-53.52%-27.78%
ETON
ETON PHARMACEUTICALS INC
$93.00M$35.30M$1.48M$913.00k$0.0435.69%134.30%N/AN/A
HLN
HALEON PLC
$39.29B$14.31B$2.70B$1.33B$0.299.36%N/A4.33%N/A
PBH
PRESTIGE CONSUMER HEALTHCARE INC
$3.23B$1.13B$380.01M$209.34M$4.21-0.21%2.89%N/AN/A
ACB
AURORA CANNABIS INC
$351.22M$199.23M-$66.17M-$106.90M-$3.9630.77%17.87%N/AN/A2024-06-12
DVAX
DYNAVAX TECHNOLOGIES CORP
$1.45B$236.15M$22.19M$9.22M$0.07-63.98%76.45%-96.24%N/A2024-05-23
TLPH
TALPHERA INC
$18.35M$651.00k-$13.69M-$14.20M-$0.85N/A-20.68%N/AN/A
UPC
UNIVERSE PHARMACEUTICALS INC
$9.44M$32.31M-$3.18M-$6.16M-$1.70-19.52%N/AN/AN/A
TXMD
THERAPEUTICSMD INC
$25.60M$1.20M-$6.47M-$7.41M-$0.68-98.28%-40.64%N/AN/A2024-06-25
EOLS
EVOLUS INC
$850.88M$219.70M-$38.05M-$60.00M-$1.0440.45%N/AN/AN/A
EGRX
EAGLE PHARMACEUTICALS INC
$61.82M$257.55M$57.18M$11.95M$0.92-5.38%3.61%-49.73%-14.47%
ORGO
ORGANOGENESIS HOLDINGS INC
$363.25M$435.47M$36.49M$5.82M$0.04-5.62%15.16%-63.64%N/A
TKNO
ALPHA TEKNOVA INC
$73.07M$36.85M-$29.00M-$36.06M-$1.04-6.45%N/AN/AN/A
OPTN
OPTINOSE INC
$142.43M$74.02M-$10.52M-$30.76M-$0.270.90%47.30%N/AN/A2024-06-06
YCBD
CBDMD INC
$2.77M$21.58M-$18.76M-$25.65M-$12.24-25.00%50.53%N/AN/A
EVOK
EVOKE PHARMA INC
$4.00M$6.11M-$6.54M-$7.13M-$1.83110.49%N/AN/AN/A2024-05-22
PRGO
PERRIGO CO PLC
$4.07B$4.56B$405.80M-$7.70M-$0.06-0.07%-0.58%N/AN/A
TARO
TARO PHARMACEUTICAL INDUSTRIES LTD
$1.59B$610.83MN/A$45.70M$1.227.23%-1.69%0.00%-31.12%2024-05-20
QLI
QILIAN INTERNATIONAL HOLDING GROUP LTD
$24.38M$46.47M-$6.52M-$7.78M-$0.22-28.35%-1.60%N/AN/A
SUPN
SUPERNUS PHARMACEUTICALS INC
$1.60B$597.40M$79.91M-$15.51M-$0.29-10.64%8.14%N/AN/A2024-05-23
ESPR
ESPERION THERAPEUTICS INC
$447.13M$229.74M-$27.81M-$86.51M-$0.97183.74%9.58%N/AN/A2024-05-20
RMTI
ROCKWELL MEDICAL INC
$53.51M$86.62M-$2.20M-$8.42M-$0.3613.45%6.24%N/AN/A
INCR
INTERCURE LTD
$149.93M$94.81M-$10.66M-$16.52M-$0.36-10.79%N/AN/AN/A
PETQ
PETIQ INC
$594.14M$1.12B$86.37M$7.34M$0.2519.61%14.79%N/A12.30%
ALIM
ALIMERA SCIENCES INC
$167.64M$90.22M$2.05M-$22.66M-$1.2361.75%12.59%N/AN/A
HUGE
FSD PHARMA INC
$12.90M$0.00-$6.09M-$7.19M-$0.19N/AN/AN/AN/A2024-07-18
AQST
AQUESTIVE THERAPEUTICS INC
$283.13M$51.50M-$17.12M-$28.77M-$0.4310.65%-1.89%N/AN/A2024-06-20
RDHL
REDHILL BIOPHARMA LTD
$18.13M$6.53M$14.62M$23.92M$4.00-89.43%-4.82%N/AN/A2024-06-10
AVDL
AVADEL PHARMACEUTICALS PLC
$1.49B$55.14M-$145.72M-$156.83M-$1.83N/A-8.59%N/AN/A
HROW
HARROW INC
$593.00M$138.68M$4.49M-$31.33M-$0.9249.79%25.36%N/AN/A
DRRX
DURECT CORP
$28.87M$8.32M-$20.65M-$23.28M-$0.83-57.16%-12.17%N/AN/A
GHSI
GUARDION HEALTH SCIENCES INC
$10.93M$12.06M-$5.10M-$5.12M-$4.021.79%64.82%N/AN/A
AYTU
AYTU BIOPHARMA INC
$16.37M$93.76M-$4.17M-$13.68M-$2.44-9.95%70.38%N/AN/A
PTPI
PETROS PHARMACEUTICALS INC
$4.10M$4.69M-$5.12M-$20.46M-$7.37-22.36%N/AN/AN/A
DERM
JOURNEY MEDICAL CORP
$69.04M$80.00M$1.26M-$4.16M-$0.2027.82%N/AN/AN/A2024-06-25
SXTC
CHINA SXT PHARMACEUTICALS INC
$837.03k$29.92k-$13.36M-$14.14M-$26.97-91.18%-27.77%N/AN/A
BFRI
BIOFRONTERA INC
$5.45M$33.25M-$20.14M-$23.09M-$10.2020.23%N/AN/AN/A2024-06-12
ASRT
ASSERTIO HOLDINGS INC
$101.78M$142.05M-$222.38M-$332.97M-$3.64-12.40%-10.05%N/AN/A
EBS
EMERGENT BIOSOLUTIONS INC
$290.83M$1.19B-$345.80M-$565.20M-$10.9421.32%6.75%N/AN/A2024-05-23
VTRS
VIATRIS INC
$13.07B$15.36B$3.35B-$56.10M-$0.03-2.78%6.44%N/AN/A
INDV
INDIVIOR PLC
$2.32B$1.12B$75.00M$5.00M$0.0418.57%N/AN/AN/A
CYTH
CYCLO THERAPEUTICS INC
$40.06M$1.13M-$19.38M-$19.39M-$1.00-15.51%1.72%N/AN/A
FLGC
FLORA GROWTH CORP
$16.79M$74.78M-$55.83M-$56.11M-$7.6054.13%N/AN/AN/A
KALA
KALA BIO INC
$18.45M$0.00-$33.22M-$39.55M-$14.96-100.00%-100.00%N/AN/A2024-06-11
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
$67.80M$0.00-$5.10M-$5.87M-$0.45N/AN/AN/AN/A
CRDL
CARDIOL THERAPEUTICS INC
$139.09M$0.00-$21.87M-$22.06M-$0.34N/AN/AN/AN/A
CPIX
CUMBERLAND PHARMACEUTICALS INC
$21.43M$38.83M-$1.82M-$8.42M-$0.59-3.08%5.66%N/AN/A
CTLT
CATALENT INC
$10.02B$4.14B-$524.00M-$1.18B-$6.49-8.01%10.79%N/AN/A2024-05-29
LFCR
LIFECORE BIOMEDICAL INC
$179.31M$103.27M-$68.32M-$99.56M-$3.32-7.19%-27.74%N/AN/A2024-05-30
OGI
ORGANIGRAM HOLDINGS INC
$190.83MN/AN/AN/AN/AN/AN/AN/AN/A2024-07-11
SNOA
SONOMA PHARMACEUTICALS INC
$3.68M$12.31M-$4.95M-$5.08M-$0.94-1.96%-7.57%N/AN/A2024-06-19
CGC
CANOPY GROWTH CORP
$988.59M$246.67M-$907.84M-$952.65M-$16.21-10.51%16.69%N/AN/A2024-05-30
PRFX
PAINREFORM LTD
$1.57M$0.00-$12.72M-$12.54M-$7.66N/AN/AN/AN/A
EVO
EVOTEC SE
$1.86BN/AN/AN/AN/AN/AN/AN/AN/A2024-06-10
ALVO
ALVOTECH
$3.60B$93.38M-$359.68M-$551.73M-$2.439.84%N/AN/AN/A2024-05-21
IXHL
INCANNEX HEALTHCARE INC
$39.68MN/AN/AN/AN/AN/AN/AN/AN/A
TAK
TAKEDA PHARMACEUTICAL CO LTD
$41.48B$27.12B$6.36B$916.46M$0.29-7.42%8.11%-60.57%-13.81%
BHC
BAUSCH HEALTH COMPANIES INC
$2.48B$8.97B$2.34B-$455.00M-$1.2310.01%1.31%N/AN/A
IRWD
IRONWOOD PHARMACEUTICALS INC
$1.03B$413.55M-$977.81M-$1.05B-$6.77-0.86%3.62%N/AN/A
AKAN
AKANDA CORP
$1.53M$2.16M-$27.74M-$32.28M-$7.16-17.55%N/AN/AN/A
SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS INC
$6.73M$0.00-$4.96M-$7.35M-$0.46N/AN/AN/AN/A
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
$18.45B$16.00B$1.64B-$493.00M-$0.447.22%-1.61%N/AN/A
ELAN
ELANCO ANIMAL HEALTH INC
$8.49B$4.37B-$325.00M-$1.30B-$2.65-1.76%7.35%N/AN/A2024-05-30
CPHI
CHINA PHARMA HOLDINGS INC
$5.21M$6.42M-$454.86k-$3.56M-$0.68-24.11%-11.22%N/AN/A
AMRX
AMNEAL PHARMACEUTICALS INC
$2.11B$2.50B$299.04M-$168.69M-$0.749.82%6.35%N/AN/A
LSDI
LUCY SCIENTIFIC DISCOVERY INC
$2.58M$16.73k-$9.75M-$11.30M-$7.00N/AN/AN/AN/A
BGXX
BRIGHT GREEN CORP
$43.74M$0.00-$12.49M-$13.13M-$0.07N/AN/AN/AN/A

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in May 2024?

According to Zen Score, the 3 best pharma stocks to buy right now are:

1. Kamada (NASDAQ:KMDA)


Kamada (NASDAQ:KMDA) is the top pharmaceutical stock with a Zen Score of 65, which is 40 points higher than the pharmaceutical industry average of 25. It passed 20 out of 33 due diligence checks and has strong fundamentals. Kamada has seen its stock return 12.82% over the past year, overperforming other pharmaceutical stocks by 15 percentage points.

Kamada has an average 1 year price target of $11.00, an upside of 104.84% from Kamada's current stock price of $5.37.

Kamada stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Kamada, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Neurocrine Biosciences (NASDAQ:NBIX)


Neurocrine Biosciences (NASDAQ:NBIX) is the second best pharmaceutical stock with a Zen Score of 64, which is 39 points higher than the pharmaceutical industry average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Neurocrine Biosciences has seen its stock return 49.35% over the past year, overperforming other pharmaceutical stocks by 51 percentage points.

Neurocrine Biosciences has an average 1 year price target of $159.06, an upside of 11.79% from Neurocrine Biosciences's current stock price of $142.29.

Neurocrine Biosciences stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 16 analysts covering Neurocrine Biosciences, 56.25% have issued a Strong Buy rating, 25% have issued a Buy, 18.75% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the third best pharmaceutical stock with a Zen Score of 64, which is 39 points higher than the pharmaceutical industry average of 25. It passed 20 out of 33 due diligence checks and has strong fundamentals. Pacira Biosciences has seen its stock lose -23.81% over the past year, underperforming other pharmaceutical stocks by -22 percentage points.

Pacira Biosciences has an average 1 year price target of $46.71, an upside of 51.57% from Pacira Biosciences's current stock price of $30.82.

Pacira Biosciences stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Pacira Biosciences, 28.57% have issued a Strong Buy rating, 71.43% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 6 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 7.88%, which is 5 percentage points higher than the pharmaceutical industry average of 2.96%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

2. Alkermes (NASDAQ:ALKS)


Alkermes (NASDAQ:ALKS) has an annual dividend yield of 4.43%, which is 1 percentage points higher than the pharmaceutical industry average of 2.96%.

Alkermes's dividend payout ratio of 40.8% indicates that its high dividend yield is sustainable for the long-term.

3. Perrigo Co (NYSE:PRGO)


Perrigo Co (NYSE:PRGO) has an annual dividend yield of 3.67%, which is 1 percentage points higher than the pharmaceutical industry average of 2.96%. Perrigo Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Perrigo Co's dividend has shown consistent growth over the last 10 years.

Perrigo Co's dividend payout ratio of -1,825% indicates that its dividend yield might not be sustainable for the long-term.

Why are pharmaceutical stocks down?

Pharmaceutical stocks were down -0.75% in the last day, and up 1.1% over the last week. Tilray Brands was the among the top losers in the drug manufacturers - specialty & generic industry, dropping -6.6% yesterday.

Tilray Brands shares are trading lower after the company announced an at-the-market program to fund acquisitions.

What are the most undervalued pharmaceutical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical stocks right now are:

1. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 83 points higher than the pharmaceutical industry average of 17. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -23.81% in the past year. It has underperformed other stocks in the pharmaceutical industry by -22 percentage points.

2. Collegium Pharmaceutical (NASDAQ:COLL)


Collegium Pharmaceutical (NASDAQ:COLL) is the second most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Collegium Pharmaceutical has a valuation score of 86, which is 69 points higher than the pharmaceutical industry average of 17. It passed 6 out of 7 valuation due diligence checks.

Collegium Pharmaceutical's stock has gained 42.23% in the past year. It has overperformed other stocks in the pharmaceutical industry by 44 percentage points.

3. Kamada (NASDAQ:KMDA)


Kamada (NASDAQ:KMDA) is the third most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Kamada has a valuation score of 86, which is 69 points higher than the pharmaceutical industry average of 17. It passed 6 out of 7 valuation due diligence checks.

Kamada's stock has gained 12.82% in the past year. It has overperformed other stocks in the pharmaceutical industry by 15 percentage points.

Are pharmaceutical stocks a good buy now?

58.49% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 32.29% over the next year.

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is -1.01x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.